Tianjin Ringpu Bio-Technology Company Description

Tianjin Ringpu Bio-Technology Co.,Ltd. engages in the research and development, production, and sale of veterinary raw materials, drug preparation, functional additives, and veterinary biological products.

The company offers anthelmintics, pet vaccines, ear canal treatment drugs, anesthetic analgesics, antibiotics, antivirals, various internal medicine drugs, as well as disinfectant products, including compound potassium peroxymonosulphate, deciquam solution, and glutaral solution, API products, herbal medicines, and cleaning agents for poultry, waterfowl, livestock, ruminant, and companion animals.

The company also provides disease diagnosis and testing services, consisting of animal disease diagnosis and testing, animal-derives food testing, and feed and pharmaceutical analysis testing; veterinary drug evaluation services comprising preclinical safety evaluation and clinical evaluation services for universities, research institutes, enterprises, and other entities; and socialized veterinary services, such as monitoring, testing, immunizing, quarantine, and investigating epidemiological surveys related to animal diseases to local governments.

Tianjin Ringpu Bio-Technology Co.,Ltd. was founded in 1998 and is headquartered in Tianjin, China.

Tianjin Ringpu Bio-Technology Co.,Ltd.

Country	China
Founded	1998
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	2,900
CEO	Lei Xu

Contact Details

Address: No. 1, East 9th Road Tianjin, 300308 China
Phone	86 22 8895 8118
Website	ringpu.com

Stock Details

Ticker Symbol	300119
Exchange	Shenzhen Stock Exchange
Fiscal Year	January - December
Reporting Currency	CNY
ISIN Number	CNE100000TV1
SIC Code	2836

Key Executives

Name	Position
Lei Xu	GM and Director
Gaibian Li	Financial Manager
Ailing Liu	Deputy GM and Director
Xiutong Zhu	Non-Independent Director and Deputy GM
Gang Xie	Board Secretary
Yongjun You	Deputy General Manager
Endong Bao Ph.D.	Chief Inspector of Technology Centre